fenamic acid

Fenamic acid (N-Phenylanthranilic acid) 是氯通道阻滞剂。

Tolfenamic Acid (GEA 6414) 是一种非甾体抗炎剂和抗癌剂，可用于治疗偏头痛的症状。它能选择性地抑制COX-2的活性，在 LPS 诱导的犬 DH82 单核细胞 巨噬细胞中，对COX-2的IC50值为 13.49 μM(3.53 μg mL)。

Flufenamic acid (Arlef) 是一种非甾体类抗炎剂，是一种邻氨基苯甲酸衍生物，具有镇痛、抗炎和解热的特性。 它用于肌肉骨骼和关节疾病。

Mefenamic acid (CN-35355) 是一种非甾体抗炎剂，可竞争性抑制hCOX-1和hCOX-2，IC50值分别为 40 nM 和 3 μM。

Meclofenamic acid sodium (Movens) 是一种非甾体抗炎药，可用于治疗关节炎 、缓解疼痛、痛经和严重月经失血。它是一种非选择性的缝隙连接阻断剂，是一种高选择性的脂肪和肥胖相关酶抑制剂。

Meclofenamic acid (Meclofenamate) 是一种非特异性 gap-junction 阻滞剂和特异性脂肪量和肥胖相关 (FTO) 酶抑制剂。 Meclofenamic acid 具有抗炎活性。

Flufenamic acid-d4 is intended for use as an internal standard for the quantification of flufenamic acid by GC- or LC-MS. Flufenamic acid is a non-steroidal anti-inflammatory drug (NSAID) and COX inhibitor (IC50s = 3 and 9.3 µM for human COX-1 and COX-2, respectively). Flufenamic acid inhibits TNF-α-induced increases in COX-2 levels and NF-κB activation in HT-29 colon cancer cells in a concentration-dependent manner. It inhibits calcium influx induced by fMLP or A23187 in human polymorphonuclear leukocytes (PMN) with IC50 values of 29 and 14 µM, respectively. Flufenamic acid also activates various ion channels, including transient receptor potential canonical 6 (TRPC6) and the large-conductance calcium-activated potassium channel (KCa1.1). It also inhibits various ion channels, including TRPC3 and the cystic fibrosis transmembrane conductance regulator (CFTR). Flufenamic acid (20 mg kg) reduces increases in intestinal fluid secretion and intestinal barrier disruption in mice ......

Enfenamic acid 是一种能够抑制伤口愈合的非甾体抗炎药。

MefenaMic Acid-d4 是 MefenaMic Acid 的氘代化合物。MefenaMic Acid 的 CAS 号为 61-68-7。Mefenamic acid 是一种非甾体抗炎剂，可竞争性抑制hCOX-1和hCOX-2，IC50值分别为 40 nM 和 3 μM。

ABC294640, also known as Opaganib, is an orally available, aryladamantane compound and selective inhibitor of sphingosine kinase-2 (SK2) with potential antineoplastic activity. Upon administration, ABC294640 competitively binds to and inhibits SK2, thereby preventing the phosphorylation of the pro-apoptotic amino alcohol sphingosine to sphingosine 1-phosphate (S1P), the lipid mediator that is pro-survival and critical for immunomodulation. This may eventually lead to the induction of apoptosis and may result in an inhibition of cell proliferation in cancer cells overexpressing SK2.